Predict your next investment

SOFTWARE (NON-INTERNET/MOBILE) | Scientific, Engineering Software
manctl.com

See what CB Insights has to offer

Stage

Acquired | Acquired

About ManCTL

ManCTL is a provider of advanced 3D scanning technologies. The company is the developer of Skanect, a 3D scanning desktop application that allows users to capture highly accurate, full-color 3D models of objects, people, rooms, and more using standard Windows computers and low-cost depth sensors including Microsoft Kinect, ASUS Xtion and PrimeSense Carmine.In June 2013, ManCTL was acquired by Occipital. The valuation of ManCTL was undisclosed. Other terms of the deal were not released.

ManCTL Headquarter Location

Lyon,

France

Latest ManCTL News

Occipital Ships 3D Capture Software For Mac

Jul 11, 2013

Tweet Boulder- and San Francisco-based Occpital , the developer of mobile apps, has just released a new, 3D capture and scanning software package for the Mac--thanks to its recent acquisition of ManCTL. Occipital's Skanect team announced the addition of its 3D capture package for the Mac Wednesday, saying that the software runs on the Macbook Pro, Macbook Air, Mac Mini, and Mac Pro. The software is used by games, animation, and other developers to do 3D motion capture, using consumer grade, 3D cameras. The software had been in Beta. Occipital develops mobile panorama app 360 Panorama, and also was the creator of RedLaser, which it sold to eBay back in 2010.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.